The US Food and Drug Administration (USFDA) has conducted its pre-approval inspection at Syngene International’s Biologics facility in Bangalore from November 07, 2022 till November 15, 2022. The inspection was completed successfully without 483 observations.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
